May 31, 2013,
MUMBAI—Ranbaxy Laboratories Ltd. 500359.BY -2.63% Friday defended the quality of its products, weeks after a U.S. probe ended with the drug maker agreeing to pay a criminal fine for selling adulterated drugs.
"All Ranbaxy products currently in the Indian market and globally are safe and efficacious," the company said in a statement.
Ranbaxy "stands by the quality of every medicine" that it makes and sells, said the Indian company, now majority-owned by Japan’s Daiichi Sankyo Co. 4568.TO -1.60%